AMBQ
Ambiq Micro, Inc.
There isn't enough reported data to score AMBQ yet.
ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
AMBQ Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
AMBQ's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
AMBQ PE Valuation
AMBQ has no meaningful PE right now: it lost money over the past year.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
AMBQ Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect AMBQ's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
AMBQ Earnings Per Share
AMBQ and ASTS do not have enough comparable growth data to identify a winner.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
AMBQ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $38.1M | +110% |
| Q2 2026 | $33.9M | +90% |
| Q1 2026 | $25.1M | +59% |
| Q4 2025 | $20.7M | +2% |
| Q3 2025 | $18.2M | -10% |
| Q2 2025 | $17.9M | -12% |
| Q1 2025 | $15.7M | +3.4% |
AMBQ's revenue has grown year over year for four quarters in a row: $38M last quarter, up 110% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -26% | +29 points |
| Q2 2026 | -26% | +24 points |
| Q1 2026 | -47% | +19 points |
| Q4 2025 | -58% | +1 points |
| Q3 2025 | -55% | -5.5 points |
| Q2 2025 | -49% | +4.9 points |
| Q1 2025 | -66% | -5.3 points |
| Q4 2024 | -59% | N/A |
AMBQ has the edge over ASTS on profitability, with a higher operating margin.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over AMBQ on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
AMBQ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.7M | +$324K |
| Q1 2026 | -$11.2M | -3953% |
| Q4 2025 | -$4.1M | -$4M |
| Q3 2025 | -$5M | +$11.6M |
| Q1 2025 | $290K | +$3.8M |
AMBQ has burned cash in almost every quarter: −$29M over the past year, against −$22M the year before.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
AMBQ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +12% | +2.5M shares |
| 1 year | +78% | +10.7M shares |
AMBQ has 24M diluted shares, up 78% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has the edge over AMBQ on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
AMBQ Net Leverage
AMBQ's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AMBQ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.1 | Neutral |
| Stochastic | 17.1 | Oversold |
AMBQ's weekly RSI is 44 (neutral) and its Stochastic is 17 (oversold).
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
AMBQ PE vs Technology Sector
AMBQ has no meaningful PE right now: it lost money over the past year.
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
AMBQ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $54.0 | 9.6% below |
| 20 week MA | $62.1 | 21% below |
| 50 week MA | $50.3 | 3.1% below |
ASTS has stronger trend alignment. AMBQ is above 0 of 3 weekly averages versus ASTS above 1 of 5.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
AMBQ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $39.5 | $30.0 | -24% |
| 2026 YTD | $30.0 | $48.8 | +63% |
AMBQ has the edge over ASTS on returns for 2026, with the stronger performance.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.